The goal of comparative clinical effectiveness research (CER) is to meet the requirements of everybody involved in clinical decision-making, including patients, their caregivers, clinicians, payers, and policymakers. By evaluating options for prevention, diagnosis, or treatment, CER encourages better and more individualised healthcare decisions, improved clinical results, and the abolition of unnecessary care and spending. Patient, clinician, and payer information needs are prioritised by PCORI, as are the involvement of all pertinent parties throughout the whole study process and consideration of the potential for "treatment heterogeneity." Randomized and observational CER research with a variety of study designs are both funded by PCORI. In order to improve CER's patient-centeredness, efficiency, and affordability as well as its ability to influence practise change, it has invested in PCORnet, a nationwide clinical research network.







Title : Using collaborative civil discourse to address AI issues
Nina Beaman, Mary Baldwin University, United States
Title : Managing comprehensive communication and cooperation in intelligent and ethical personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany